Cardiovascular calcification in patients with end-stage renal disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Pathology

Background:

• Vascular calcifications are frequent in chronic renal disease, affecting arterial elasticity and survival.
• Risk factors include age, dialysis duration, diabetes, high phosphate, calcium-based binders, and inflammation.
• Vascular smooth muscle cells uptake phosphate, transforming into osteoblast-like cells, contributing to calcification.

Purpose of the Study:

• To review the pathophysiology and risk factors of vascular calcification in chronic renal disease.
• To highlight the role of vascular smooth muscle cell transformation and calcification inhibitors.
• To emphasize preventive strategies, particularly phosphate binder selection.

Main Methods:

• Literature review of vascular calcification in chronic renal disease.
• Analysis of risk factors, cellular mechanisms, and inhibitory factors.
• Evaluation of preventive measures and treatment outcomes.

Main Results:

• Vascular calcifications are linked to reduced arterial elasticity and higher mortality in dialysis patients.
• Phosphate concentration, calcium-based binders, and inflammation are key contributors.
• Matrix Gla protein and fetuin-A are identified calcification inhibitors; low fetuin-A correlates with increased mortality.

Conclusions:

• Vascular calcification is a significant complication of chronic renal disease with multifactorial causes.
• Understanding the cellular mechanisms and risk factors is crucial for prevention.
• Substituting calcium-containing with non-calcium-containing phosphate binders is a key preventive strategy.